---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-008658"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2026-03-03T23:59:59+00:00"
generated_at: "2026-05-15T22:28:10.606557+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical confirms no business disruption amid Middle East events, progresses LIBERTY commercial launch

## Summary
- No business disruption in USA or Israel; all personnel operational, lead manufacturing partner fully functional.
- LIBERTY system received FDA clearance; limited market release began late 2025; full market release at SIR April 2026.
- Hired additional U.S. sales representatives and a Director of Health Economics and Outcomes Research (HEOR) for commercial expansion.
- Sufficient U.S. inventory maintained; building additional stock via third-party logistics partner for anticipated demand.

## SEC filing metadata
- accession: 0001493152-26-008658
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2026-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315226008658/0001493152-26-008658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315226008658/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-008658
- JSON: https://secwatch.observer/filing/0001493152-26-008658.json
- Plain text: https://secwatch.observer/filing/0001493152-26-008658.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.